What is Transradial Access Market?
Transradial access devices are widely used in coronary procedures to lower complications. Transradial access devices are used for peripheral artery diseases such as atherosclerosis diseases of extracranial carotid and vertebral, abdominal mesenteric, and renal as well as extremity arteries. Rising the adoption of interventional procedures with radial artery access devices, increase in the prevalence of lifestyle diseases, surge in prevalence of obesity, the surge in demand for cardiovascular interventional procedures, and increase in cardiovascular diseases are the major driving global transradial access market.
The market study is being classified by Type (Catheters, Guidewires, Sheaths & Sheath Introducers and Accessories), by Application (Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics and Testing) and major geographies with country level break-up. According to AMA, the Global Transradial Access market is expected to see growth rate of 7.43%
Becton, Dickinson and Company (United States), Terumo Corporation (Japan), Teleflex Incorporated (United States), Smiths Group Plc (United Kingdom), Edward Lifesciences Corporation (United States), Medtronic (Ireland), Merit Medical System, Inc. (United States), Boston Scientific (United States), NIPRO Medical Corporation (United States) and AngioDynamics (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Ameco Medical Industries (Egypt), OSCOR Inc. (United States) and Cordis Corporation (United States).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Transradial Access market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Transradial Access market by Type, Application and Region.
On the basis of geography, the market of Transradial Access has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Rising Preference for Interventional Procedures Using Radial Artery Access
- Growing Prevalence of Lifestyle Diseases and Obesity
- Increasing Use of Radial Access Devices in Pediatric Patients
Market Trend
- Increasing Number of Chemotherapy Procedures
Restraints
- High Costs Involved in the Placement and Maintenance of Vascular Access Devices
- Product Recalls and Failures
Opportunities
- Technological Advancements and Development in the Transradial Access
Challenges
- Dearth of Highly Skilled Professionals
- Risks Associated With Radial Access Devices
Market Leaders and some development strategies
16th May 2019, Cordis has announced the full US launch of its Radial 360 portfolio, offering a complete range of products to facilitate the transradial approach (TRA) for interventional cardiology procedures. The transradial approach uses the radial artery in the wrist to access the arterial system, rather than the femoral artery in the groin.
On 21st January 2020, Terumo Europe N.V., a leading medical device company has announced the launch of a new randomized clinical trial: the DIStal vs COnventional RADIAL access trial (DISCO RADIAL). The trial compares the novel distal radial access with the conventional radial access approach, in terms of radial occlusion rates (RAO) at discharge.
Key Target Audience
Transradial Access Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others